JPWO2020218562A1 - - Google Patents

Info

Publication number
JPWO2020218562A1
JPWO2020218562A1 JP2021516292A JP2021516292A JPWO2020218562A1 JP WO2020218562 A1 JPWO2020218562 A1 JP WO2020218562A1 JP 2021516292 A JP2021516292 A JP 2021516292A JP 2021516292 A JP2021516292 A JP 2021516292A JP WO2020218562 A1 JPWO2020218562 A1 JP WO2020218562A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021516292A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2020218562A1 publication Critical patent/JPWO2020218562A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2021516292A 2019-04-26 2020-04-24 Pending JPWO2020218562A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/JP2019/017995 WO2020217472A1 (ja) 2019-04-26 2019-04-26 治療抵抗性がんの予防又は治療用の医薬組成物
PCT/JP2020/017805 WO2020218562A1 (ja) 2019-04-26 2020-04-24 治療抵抗性がんの予防又は治療用の医薬組成物

Publications (1)

Publication Number Publication Date
JPWO2020218562A1 true JPWO2020218562A1 (ja) 2020-10-29

Family

ID=72941599

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021516292A Pending JPWO2020218562A1 (ja) 2019-04-26 2020-04-24

Country Status (5)

Country Link
US (1) US20220175925A1 (ja)
EP (1) EP3960243A4 (ja)
JP (1) JPWO2020218562A1 (ja)
CN (1) CN113825528A (ja)
WO (2) WO2020217472A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7474773B2 (ja) 2019-02-13 2024-04-25 アルフェウス メディカル，インク． 非侵襲的音響化学療法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015125732A1 (ja) * 2014-02-21 2015-08-27 Ｓｂｉファーマ株式会社 治療抵抗性がんの予防用又は治療用組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005132766A (ja) 2003-10-30 2005-05-26 Cosmo Oil Co Ltd 光動力学的癌治療薬
US8927761B2 (en) * 2012-06-28 2015-01-06 Photocure Asa Form of hexyl-5-aminolevulinate hydrochloride and methods of using the same
GB2525432A (en) 2014-04-24 2015-10-28 Univ Oslo Hf Modification of extracorporeal photopheresis technology with porphyrin precursors
EP3439666A4 (en) * 2016-05-20 2019-12-11 The University of Chicago NANOPARTICLES FOR CHEMOTHERAPY, TARGETED THERAPY, PHOTODYNAMIC THERAPY, IMMUNOTHERAPY AND ANY COMBINATION THEREOF
US20220314021A1 (en) * 2019-02-19 2022-10-06 Otsuka Electronics Co., Ltd. Method for determining condition parameters for photodynamic therapy and photodynamic therapy apparatus

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015125732A1 (ja) * 2014-02-21 2015-08-27 Ｓｂｉファーマ株式会社 治療抵抗性がんの予防用又は治療用組成物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHIO-SRICHAN, SIRINART ET AL.: "Toxicity and phototoxicity of Hypocrellin A on malignant human cell lines, evidence of a synergistic", JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B: BIOLOGY, vol. Vol. 99, Issue 2, JPN6020020912, 6 May 2010 (2010-05-06), pages 100 - 104, ISSN: 0005077393 *
TAKAHASHI, HIDETOSHI ET AL.: "ATX-S10(Na)-photodynamic therapy inhibits cytokine secretion and proliferation of lymphocytes", JOURNAL OF DERMATOLOGICAL SCIENCE, vol. Vol. 49, Issue 2, JPN6019029432, February 2008 (2008-02-01), pages 174 - 177, ISSN: 0005077391 *
XU, LINGLING ET AL.: " Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction", RETROVIROLOGY, vol. 16, no. 5, JPN6019029433, 19 February 2019 (2019-02-19), XP055758340, ISSN: 0005077392, DOI: 10.1186/s12977-019-0467-0 *

Also Published As

Publication number Publication date
EP3960243A4 (en) 2023-01-18
EP3960243A1 (en) 2022-03-02
TW202106292A (zh) 2021-02-16
US20220175925A1 (en) 2022-06-09
WO2020218562A1 (ja) 2020-10-29
CN113825528A (zh) 2021-12-21
WO2020217472A1 (ja) 2020-10-29

Similar Documents

Publication Publication Date Title
BR112021017339A2 (ja)
BR112021013854A2 (ja)
BR112021018450A2 (ja)
AU2020104490A4 (ja)
BR112021017234A2 (ja)
BR112021017355A2 (ja)
BR112021018102A2 (ja)
BR112021017173A2 (ja)
BR112021017083A2 (ja)
BR112021017637A2 (ja)
BR112021018452A2 (ja)
BR112021012348A2 (ja)
BR112021018250A2 (ja)
BR112021017703A2 (ja)
BR112021013944A2 (ja)
BR112021013128A2 (ja)
BR112021018484A2 (ja)
BR112021015080A2 (ja)
JPWO2020218562A1 (ja)
BR112021016205A2 (ja)
BR112021016996A2 (ja)
BR112021017010A2 (ja)
AT524962A5 (ja)
BR112019016136A2 (ja)
BR112021016821A2 (ja)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221018

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230606

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230807

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231005

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240109

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20240502